Horizon Pharma Files Patent Infringement Suit Against Par
Horizon Pharma (NASDAQ: HZNP) today announced it has filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Par Pharmaceutical, and related to an Abbreviated New Drug Application that Par filed with the U.S. Food and Drug Administration to market a generic version of DUEXIS tablets.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.